HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma.

AuthorsRena Morita, Satoshi Hashino, Shinichi Shirai, Noriaki Fujita, Masahiro Onozawa, Kaoru Kahata, Takeshi Kondo, Masahiro Imamura, Masahiro Asaka
JournalInternational journal of hematology (Int J Hematol) Vol. 88 Issue 2 Pg. 248-250 (Sep 2008) ISSN: 0925-5710 [Print] Japan
PMID18636313 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Boronic Acids
  • Glucocorticoids
  • Pyrazines
  • Bortezomib
  • Dexamethasone
Topics
  • Antineoplastic Agents (adverse effects)
  • Boronic Acids (adverse effects)
  • Bortezomib
  • Dexamethasone (adverse effects)
  • Drug Therapy, Combination
  • Glucocorticoids (adverse effects)
  • Humans
  • Male
  • Microcirculation
  • Middle Aged
  • Multiple Myeloma (drug therapy)
  • Pyrazines (adverse effects)
  • Thrombosis (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: